---
title: "BLUE SAIL MEDICAL's subsidiary's next-generation recyclable transcatheter aortic valve replacement delivery system has obtained CE certification"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/246377366.md"
description: "According to the Zhitong Finance APP, BLUE SAIL MEDICAL announced that its subsidiary, NVTGmbH in the cardiovascular division, has developed a new generation of recyclable transcatheter aortic valve replacement (TAVR) delivery system IMPERIA™ (referred to as \"IMPERIA™ delivery system\"), which has obtained CE certification from the European Union. This delivery system is used in conjunction with the company's already listed ALLEGRA™ series aortic valves to achieve recyclable functionality"
datetime: "2025-06-27T08:31:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/246377366.md)
  - [en](https://longbridge.com/en/news/246377366.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/246377366.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/246377366.md) | [繁體中文](https://longbridge.com/zh-HK/news/246377366.md)


# BLUE SAIL MEDICAL's subsidiary's next-generation recyclable transcatheter aortic valve replacement delivery system has obtained CE certification

According to the Zhitong Finance APP, BLUE SAIL MEDICAL (002382.SZ) announced that its subsidiary, Germany's NVTGmbH, has developed a new generation of recyclable transcatheter aortic valve replacement (TAVR) delivery system IMPERIA™ (referred to as "IMPERIA™ delivery system"), which has obtained CE certification from the European Union. This delivery system is used in conjunction with the company's already listed ALLEGRA™ series aortic valves to achieve recyclable functionality

### 相关股票

- [BLUE SAIL MEDICAL (002382.CN)](https://longbridge.com/zh-CN/quote/002382.CN.md)

## 相关资讯与研究

- [Tennis-Gauff retires from Indian Wells match due to elbow pain](https://longbridge.com/zh-CN/news/278312995.md)
- [Bug that wiped customer data saved the day – and a contract](https://longbridge.com/zh-CN/news/278347746.md)
- [Tajikistan Approves Hebei Changsha Biochemical Pharmaceutical's Thrombosis Injection](https://longbridge.com/zh-CN/news/278372421.md)
- [10:07 ETIntune Physical Therapy Expands into Texas with Acquisition of Spero Rehab](https://longbridge.com/zh-CN/news/278571095.md)
- [Kainova reports positive top line results from Phase I EPRAD trial](https://longbridge.com/zh-CN/news/278702903.md)